Source link : https://www.newshealth.biz/health-news/fda-greenlights-first-gene-therapy-for-a-solid-tumor/
The FDA granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) for treating advanced synovial sarcoma, the first engineered cell therapy indicated for a solid tumor. An autologous T-cell immunotherapy, afami-cel is specifically indicated for adults with unresectable or metastatic disease who have received prior chemotherapy. For eligibility, patients need to be HLA-A*02:01P, -A*02:02P, -A*02:03P, or […]
Author : News Health
Publish date : 2024-08-02 16:50:19
Copyright for syndicated content belongs to the linked Source.
Categories